PRAX Projected Dividend Yield
Praxis Precision Medicines Inc ( NASDAQ : PRAX )Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. 21 YEAR PERFORMANCE RESULTS |
PRAX Dividend History Detail PRAX Dividend News PRAX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |